These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 10741142

  • 1. [Clinicopathological differential diagnosis of mycosis fungoides/Sézary syndrome from the cutaneous type of adult T-cell leukemia/lymphoma].
    Johno M, Ono T.
    Nihon Rinsho; 2000 Mar; 58(3):660-4. PubMed ID: 10741142
    [Abstract] [Full Text] [Related]

  • 2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [Abstract] [Full Text] [Related]

  • 3. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ.
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [Abstract] [Full Text] [Related]

  • 4. Mycosis fungoides and Sezary syndrome against a human immunodeficiency virus-positive background: case report.
    Gahongayire F.
    Int J Dermatol; 2007 Oct; 46 Suppl 1():32-5. PubMed ID: 17919204
    [Abstract] [Full Text] [Related]

  • 5. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R, Quaglino P, Novelli M, Fierro MT, Comessatti A, Peroni A, Bonello L, Bernengo MG.
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [Abstract] [Full Text] [Related]

  • 6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [Abstract] [Full Text] [Related]

  • 7. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ.
    J Clin Oncol; 2010 Nov 01; 28(31):4730-9. PubMed ID: 20855822
    [Abstract] [Full Text] [Related]

  • 8. Human T-cell leukemia virus type I or a related retrovirus in patients with mycosis fungoides/Sézary syndrome and Kaposi's sarcoma.
    Srivastava BI, Banki K, Perl A.
    Cancer Res; 1992 Aug 15; 52(16):4391-5. PubMed ID: 1353704
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N, Simon-Ackermann J, Gratchev A, Qadoumi M, Klemke CD, Stadler R, Kremer A, Radenhausen M, Henke U, Assaf C, Utikal J, Goerdt S, Dippel E.
    Dermatology; 2005 Aug 15; 211(2):84-92. PubMed ID: 16088151
    [Abstract] [Full Text] [Related]

  • 10. Mycosis fungoides and the Sézary syndrome.
    Kim YH, Hoppe RT.
    Semin Oncol; 1999 Jun 15; 26(3):276-89. PubMed ID: 10375085
    [Abstract] [Full Text] [Related]

  • 11. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A, Dhungel BM, Khan MF.
    J Cutan Pathol; 2006 Sep 15; 33 Suppl 2():12-5. PubMed ID: 16972946
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT.
    Arch Dermatol; 2003 Jul 15; 139(7):857-66. PubMed ID: 12873880
    [Abstract] [Full Text] [Related]

  • 13. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
    Fouchard N, Mahe A, Huerre M, Fraitag S, Valensi F, Macintyre E, Sanou F, de The G, Gessain A.
    Leukemia; 1998 Apr 15; 12(4):578-85. PubMed ID: 9557617
    [Abstract] [Full Text] [Related]

  • 14. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
    Grob JJ, Horchowski N, Tubiana N, Gabriel B, Gastaut JA, Hassoun J, Jouve I, Carcassone Y, Bonerandi JJ.
    Dermatologica; 1988 Apr 15; 177(2):82-97. PubMed ID: 3262542
    [Abstract] [Full Text] [Related]

  • 15. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.
    Horna P, Moscinski LC, Sokol L, Shao H.
    Cytometry B Clin Cytom; 2019 May 15; 96(3):234-241. PubMed ID: 30328260
    [Abstract] [Full Text] [Related]

  • 16. Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides.
    Cetinözman F, Jansen PM, Vermeer MH, Willemze R.
    Arch Dermatol; 2012 Dec 15; 148(12):1379-85. PubMed ID: 23247480
    [Abstract] [Full Text] [Related]

  • 17. Prognosis of 100 Japanese patients with mycosis fungoides and Sézary syndrome.
    Suzuki SY, Ito K, Ito M, Kawai K.
    J Dermatol Sci; 2010 Jan 15; 57(1):37-43. PubMed ID: 19931424
    [Abstract] [Full Text] [Related]

  • 18. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK.
    G Ital Dermatol Venereol; 2008 Dec 15; 143(6):375-83. PubMed ID: 19169210
    [Abstract] [Full Text] [Related]

  • 19. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
    Trautinger F, Knobler R, Willemze R, Peris K, Stadler R, Laroche L, D'Incan M, Ranki A, Pimpinelli N, Ortiz-Romero P, Dummer R, Estrach T, Whittaker S.
    Eur J Cancer; 2006 May 15; 42(8):1014-30. PubMed ID: 16574401
    [Abstract] [Full Text] [Related]

  • 20. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
    Benton EC, Crichton S, Talpur R, Agar NS, Fields PA, Wedgeworth E, Mitchell TJ, Cox M, Ferreira S, Liu P, Robson A, Calonje E, Stefanato CM, Wilkins B, Scarisbrick J, Wain EM, Child F, Morris S, Duvic M, Whittaker SJ.
    Eur J Cancer; 2013 Sep 15; 49(13):2859-68. PubMed ID: 23735705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.